Live feed
Filing
SC 13D/A
SC 13D/A0001387131-23-002058·Atlas Venture Fund X, L.P.
Schedule 13D ownership disclosure
Gemini Therapeutics, Inc. /DE
Security class unavailable · CUSIP: 36870G105
Event date: 2022-12-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 22,373,031
- Percent of class
- 12.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001387131-23-002058
- Form type
- SC 13D/A
- Filer
- Atlas Venture Fund X, L.P.
- CIK
- CIK 1628098
- Filed
- Feb 14, 2023
- Reporting period
- Dec 29, 2022
- Description
- Schedule 13D beneficial ownership